0
0
11/3/22 at 7:51pm
Organization
Hcplive.com
Author
Kenny Walter
30 words
0
Comments
In a late-breaking abstract, investigators assess how discontinuation of ACEi or ARBs impact disease progression for advanced CKD.
You are the first to view
https://www.hcplive.com/view/discontinuing-ras-inhibitors-decrease-long-term-egfr
Create an account
or login to join the discussion